{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:23:39Z","timestamp":1778675019394,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.schres.2018.06.059","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T13:03:06Z","timestamp":1530277386000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism"],"prefix":"10.1016","volume":"202","author":[{"given":"Marco","family":"Spangaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Bechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariachiara","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Guglielmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Mastromatteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2018.06.059_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10072-008-0866-9","article-title":"The brief assessment of cognition in schizophrenia. Normative data for the Italian population","volume":"29","author":"Anselmetti","year":"2008","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.schres.2018.06.059_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.2004.00300.x","article-title":"A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia","volume":"110","author":"Bechdolf","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.schres.2018.06.059_bb0015","first-page":"331","article-title":"Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro","volume":"29","author":"Beller","year":"2011","journal-title":"Restor. Neurol. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neulet.2007.02.076","article-title":"Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia","volume":"417","author":"Bosia","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.06.059_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2014.02.015","article-title":"Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment","volume":"217","author":"Bosia","year":"2014","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2018.06.059_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"34","key":"10.1016\/j.schres.2018.06.059_bb0035","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nbd.2012.05.003","article-title":"Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice","volume":"47","author":"Featherstone","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"2\u20133","key":"10.1016\/j.schres.2018.06.059_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0361-9230(97)00417-6","article-title":"Cellular distribution and kinetic properties of high-affinity glutamate transporters","volume":"45","author":"Gegelashvili","year":"1998","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.schres.2018.06.059_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0953-816x.2001.01664.x","article-title":"Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction","volume":"14","author":"Katagiri","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2018.06.059_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"2\u20133","key":"10.1016\/j.schres.2018.06.059_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2018.06.059_bb0075","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0080","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI66163","article-title":"Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection","volume":"124","author":"Kong","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.06.059_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.schres.2015.07.037","article-title":"COMT genotype and response to cognitive remediation in schizophrenia","volume":"168","author":"Lindenmayer","year":"2015","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20051979","article-title":"A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke","volume":"203","author":"Mallolas","year":"2006","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/glia.20027","article-title":"Role of glial amino acid transporters in synaptic transmission and brain energetics","volume":"47","author":"Marcaggi","year":"2004","journal-title":"Glia"},{"issue":"5915","key":"10.1016\/j.schres.2018.06.059_bb0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.1166102","article-title":"Changes in cortical dopamine D1 receptor binding associated with cognitive training","volume":"323","author":"McNab","year":"2009","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.06.059_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0169-328X(98)00063-1","article-title":"Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia","volume":"56","author":"Ohnuma","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.06.059_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0169-328X(00)00222-9","article-title":"Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus","volume":"85","author":"Ohnuma","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.schres.2018.06.059_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eurpsy.2013.07.003","article-title":"Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia","volume":"29","author":"Poletti","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.059_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2016.03.014","article-title":"Astroglial glutamate transporters coordinate excitatory signaling and brain energetics","volume":"98","author":"Robinson","year":"2016","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.schres.2018.06.059_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1600-0447.2002.1o214.x","article-title":"Development of specific social skills training programmes for schizophrenia patients: results of a multicentre study","volume":"105","author":"Roder","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"issue":"8","key":"10.1016\/j.schres.2018.06.059_bb0130","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1460-9568.2005.04059.x","article-title":"Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells","volume":"21","author":"Selkirk","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2018.06.059_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2012.12.019","article-title":"Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia","volume":"144","author":"Shan","year":"2013","journal-title":"Schizophr. Res."},{"issue":"6\u20137","key":"10.1016\/j.schres.2018.06.059_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.schres.2018.06.059_bb0145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1176\/appi.ajp.158.9.1393","article-title":"Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia","volume":"158","author":"Smith","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.06.059_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2012.06.030","article-title":"Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia","volume":"522","author":"Spangaro","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.schres.2018.06.059_bb0155","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2217\/pgs.14.42","article-title":"Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia","volume":"15","author":"Spangaro","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nn.4513","article-title":"Glucose utilization: still in the synapse","volume":"20","author":"Stoessl","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0165-1781(03)00256-7","article-title":"Relationship of good and poor Wisconsin card sorting test performance to illness duration in schizophrenia: a cross-sectional analysis","volume":"121","author":"Stratta","year":"2004","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2018.06.059_bb0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/glia.20172","article-title":"Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures","volume":"50","author":"Vallejo-Illarramendi","year":"2005","journal-title":"Glia"},{"issue":"Suppl 2","key":"10.1016\/j.schres.2018.06.059_bb0175","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/schbul\/sbr064","article-title":"Thinking about the future cognitive remediation therapy\u2013what works and could we do better?","volume":"37","author":"Wykes","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.schres.2018.06.059_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2015.10.012","article-title":"Common variants in SLC1A2 and schizophrenia: association and cognitive function in patients with schizophrenia and healthy individuals","volume":"169","author":"Zhang","year":"2015","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2018.06.059_bb0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.schres.2018.06.059_bb0190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1590\/S1516-44462006005000030","article-title":"A twelve-week randomized controlled study of the cognitive-behavioral integrated psychological therapy program: positive effect on the social functioning of schizophrenic patients","volume":"29","author":"Zimmer","year":"2007","journal-title":"Rev. Bras. Psiquiatr."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418304018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418304018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:50:40Z","timestamp":1544014240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418304018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":38,"alternative-id":["S0920996418304018"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.059","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}